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 Uncertainty avoidance in English and German PILs - a contrastive study 
 
 
Aim and focus 
The current study aims to compare the linguistic means used in German and English patient 
information leaflets (PILs) for patients’ understanding and behaviour concerning medicine 
intake. We focus on the expression of uncertainty avoidance. 
 
Background 
Three studies and a European guideline lie at the basis of the current study. Readability has 
been an important issue for PILs. However, Clerehan et al. (2005) already made a plea for a 
linguistic analysis of PILs beyond the level of statistical readability measures as well as the 
content-level. They applied a systemic-functional framework for the assessment of the quality 
of Australian PILs for that purpose. 
On the European level, the 2009 European Medicines Agency (EMA)’s Guideline similarly 
contains linguistic recommendations (incl. syntax and style). This recommendatory guideline 
has been elaborated by the different national legislative bodies, including the German Federal 
Institute for Drugs and Medical Devices (BfArM) and the British Medicines and Healthcare 
products Regulatory Agency (MHRA). It was also  critically analyzed in Fuchs and Götze (2009). 
Our study is further inspired by van Berkel and Gerritsen’s (2012) analysis of intercultural 
differences between Flemish and Dutch PILs, which is based on Hofstede’s (2001) concept of 




Hofstede’s  model describes Germany as a highly uncertainty avoidant culture, as opposed to 
the United Kingdom. For the current study we will compare the linguistic means for uncertainty 
avoidance in German and (UK) English PILs, as we believe uncertainty avoidance is particularly 





Our corpus consists of  post-2009 PILs issued by BfArM and MHRA, drawn from the EMA-
database. We will analyze two specific sections from the leaflets, recognized in the 2009 EMA-
Guideline, viz. section 2. Before you take XYZ and section 4. Possible side-effects, as these 
contain information which is directly relevant for patients’ risk management.  
 
Method 
Our contrastive linguistic analysis is based on the above-mentioned frameworks. One field 
which is crucial with respect to uncertainty avoidance is that of modality (e.g. X may cause a 
serious skin rash that may cause you to be hospitalized or even cause death). Another important 
domain is the expression of degree (notably expressions of frequency and severity, cf. Fuchs 
and Götze 2009, and amplifiers, cf. Pahta 2006). Clerehan et al.’s (2005: 337) framework further 
provides us with useful categories, viz. (i) rhetorical elements (is the reader informed , 
instructed, advised etc.), (ii) role relationship between writer and reader (who takes 
responsibility for the action to be undertaken when side-effects occur), and (iii) factual content, 
notably the source of information and quality or strength of evidence concerning side-effects. 
Two other key categories from Clerehan et al. are those of the technicality of (medical) 
vocabulary and lexical density. The latter is also related to explicitation and addition of non-
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